Phase III study of selpercatinib vs chemotherapy +/ − pembrolizumab in untreated RET positive non-small-cell lung cancer

Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Source Type: research